Jasper Therapeutics, Inc., (JSPR) Social Stream



Jasper Therapeutics, Inc., (JSPR): $29.36

0.54 (+1.87%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add JSPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#201 of 363

in industry

JASPER THERAPEUTICS INC (JSPR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering JSPR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-20 3 $21 $19 $20 $6.63 201.66%
2022-02-27 4 $21 $19 $20 $6.63 201.66%
2022-08-16 4 $21 $10 $16.666 $6.63 151.37%
2022-11-01 4 $21 $4 $11.666 $6.63 75.96%
2023-02-08 4 $10 $4 $7.333 $6.63 10.6%
2023-02-13 4 $8 $4 $6 $6.63 -9.5%
2023-03-09 3 $8 $6.85 $7.425 $6.63 11.99%
2023-05-16 4 $8 $6 $6.95 $6.63 4.83%
2023-10-09 5 $8 $6 $6.962 $6.63 5.01%

The Trend in the Analyst Price Target


JSPR's average price target has moved up $0.17 over the prior 39 weeks.

Over the past 39 weeks, JSPR's average upside potential has been 456.36%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-16 4 8 6.00 6.950 1.83 279.78%
2023-05-16 4 8 6.00 6.950 1.55 348.39%
2023-08-15 5 8 6.00 6.962 1.44 383.47%
2023-10-09 4 8 6.85 7.283 0.93 683.12%
2023-10-09 3 8 6.85 7.283 0.93 683.12%

JSPR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 24 months, JSPR's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • JASPER THERAPEUTICS INC's average analyst price target is higher than 184.1% of all US stocks.
  • In terms of how JASPER THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 190.36% of that group.
  • JASPER THERAPEUTICS INC's variance in analysts' estimates is lower than -508.39% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, JASPER THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 543.63% of them.

In the Pharmaceutical Products industry, CABA, AVRO, and MGTX are the three stocks most similar to JASPER THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is JSPR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!